SO
DMTX

STRS Ohio’s Dimension Therapeutics, Inc DMTX Stock Holding History

STRS Ohio’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,800
Closed -$13K – 2038
2016
Q2 		$10K Hold
1,800
– – ﹤0.01% 1889
2016
Q1 		$14K Hold
1,800
– – ﹤0.01% 1840
2015
Q4 		$20K Buy
+1,800
New +$22.8K ﹤0.01% 1856

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

STRS Ohio's DMTX Position: Q3 2016 in Review

STRS Ohio sold out of Dimension Therapeutics, Inc (DMTX) in Q3 2016, closing a stake of 1,800 shares — an estimated $13K sold.

STRS Ohio first reported a position in DMTX in Q4 2015 and held it in 3 quarters. The position peaked at $20K in Q4 2015. 54 funds tracked by Wall St. Rank hold DMTX as of Q3 2016.

  • STRS Ohio reported no remaining Dimension Therapeutics, Inc position as of Q3 2016 after selling out during the quarter.
  • STRS Ohio sold 1,800 Dimension Therapeutics, Inc shares in Q3 2016, an estimated $13K.
  • STRS Ohio first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 3 quarters.
  • STRS Ohio's Dimension Therapeutics, Inc position peaked at $20K in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q3 2016.

Based on STRS Ohio's 13F filing for Q3 2016, filed 27 Oct 2016.